Effect of gemigliptin on cardiac ischemia/reperfusion and spontaneous hypertensive rat models

Diabetes is associated with an increased risk of cardiovascular complications. Dipeptidyl peptidase-4 (DPP-IV) inhibitors are used clinically to reduce high blood glucose levels as an antidiabetic agent. However, the effect of the DPP-IV inhibitor gemigliptin on ischemia/reperfusion (I/R)-induced my...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Dae-Hwan, Park, Jinsook, Park, Sun-Hyun, Kim, Ki-Suk, Baek, Eun Bok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717789/
https://www.ncbi.nlm.nih.gov/pubmed/31496870
http://dx.doi.org/10.4196/kjpp.2019.23.5.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717789/
https://www.ncbi.nlm.nih.gov/pubmed/31496870
http://dx.doi.org/10.4196/kjpp.2019.23.5.329

Ejemplares similares